The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
This approval confirms the facility's compliance with FDA quality standards and regulatory requirements
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
RPG Life Sciences has reported total income of Rs. 186.22 crore during the period ended September 30, 2025
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Subscribe To Our Newsletter & Stay Updated
